A STATISTICAL MODEL TO STUDY COST-EFFECTIVENESS OF ANTIVIRAL TREATMENT IN HCV RECURRENCE AFTER LIVER TRANSPLANTATION

被引：0
|
作者：
Logge, Christoph [1 ]
Vettorazzi, Eik [2 ]
Fischer, Lutz [1 ]
Nashan, Bjoern [1 ]
Sterneck, Martina [1 ]
机构：
[1] Med Univ Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany
[2] Med Univ Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
519
引用
收藏
页码：553A / 553A
页数：1
相关论文
共 50 条
  • [21] The price of donation after cardiac death in liver transplantation: a prospective cost-effectiveness study
    van der Hilst, Christian S.
    IJtsma, Alexander J. C.
    Bottema, Jan T.
    van Hoek, Bart
    Dubbeld, Jeroen
    Metselaar, Herold J.
    Kazemier, Geert
    van den Berg, Aad P.
    Porte, Robert J.
    Slooff, Maarten J. H.
    TRANSPLANT INTERNATIONAL, 2013, 26 (04) : 411 - 418
  • [22] THE IMPACT OF ANTIVIRAL THERAPY ON FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION (LT)
    De Martin, Eleonora
    Senzolo, Marco
    Boninsegna, Sara
    Russo, Francesco P.
    Gambato, Martina
    Germani, Giacomo
    Vitale, Alessandro
    Zanus, Giacomo
    Brolese, Alberto
    Cillo, Umberto
    Burra, Patrizia
    TRANSPLANT INTERNATIONAL, 2009, 22 : 327 - 327
  • [23] NEW ERA OF ANTIVIRAL TREATMENT OF HCV-INFECTION AFTER LIVER TRANSPLANTATION
    Yaroshenko, Ekaterina
    Kornilov, Maxim
    Gichkun, Olga
    TRANSPLANT INTERNATIONAL, 2015, 28 : 371 - 371
  • [24] Cytomegalovirus immune globulin after liver transplantation: a cost-effectiveness analysis
    Arbo, MDJ
    Snydman, DR
    Wong, JB
    Goldberg, HS
    Schmid, CH
    Pauker, SG
    CLINICAL TRANSPLANTATION, 2000, 14 (01) : 19 - 27
  • [25] Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation
    Ladabaum, Uri
    Cheng, Shan L.
    Yao, Francis Y.
    Roberts, John P.
    CLINICAL TRANSPLANTATION, 2011, 25 (02) : 283 - 291
  • [26] Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation
    Manzia, Tommaso Maria
    Angelico, Roberta
    Toti, Luca
    Angelico, Cristina
    Quaranta, Claudia
    Parente, Alessandro
    Blasi, Francesca
    Iesari, Samuele
    Sforza, Daniele
    Baiocchi, Leonardo
    Lerut, Jan
    Tisone, Giuseppe
    LIVER TRANSPLANTATION, 2018, 24 (09) : 1199 - 1208
  • [27] FIBROSIS PROGRESSION IN NON RESPONDERS TO ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION (LT)
    De Martin, E.
    Senzolo, M.
    Ponziani, F. R.
    Pasulo, L.
    Gasbarrini, A.
    Vigano, R.
    Belli, L.
    Donato, F.
    Angelico, M.
    Di Paolo, D.
    Rendina, M.
    Miglioresi, L.
    Grazi, G.
    Morelli, M. C.
    Toniutto, P.
    Merli, M.
    Jemmolo, M.
    Gerunda, G. E.
    Fagiuoli, S.
    Burra, P.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S32 - S32
  • [28] Influence of steroids on HCV recurrence after liver transplantation: A prospective study
    Vivarelli, Marco
    Burra, Patrizia
    La Barba, Giuliano
    Canova, Daniele
    Senzolo, Marco
    Cucchetti, Alessandro
    D'Errico, Antonia
    Guido, Maria
    Merenda, Roberto
    Neri, Damele
    Zanello, Matteo
    Giannini, Federico Maria
    Grazi, Gian Luca
    Cillo, Umberto
    Pinna, Antonio Damele
    JOURNAL OF HEPATOLOGY, 2007, 47 (06) : 793 - 798
  • [29] THE BENEFIT OF ANTIVIRAL THERAPY ON FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION (LT): AN ITALIAN MULTICENTER STUDY
    De Martin, Eleonora
    Senzolo, Marco
    Ponziani, Francesca
    Vigano, Raffaella
    Belli, Luca S.
    Pinzello, Giovambattista
    Colledan, Michele
    Donato, Maria F.
    Di Paolo, Daniele
    Angelico, Mario
    Rendina, Maria
    Pompili, Maurizio
    Merli, Manuela
    Villa, Erica
    Russo, Francesco P.
    Boninsegna, Sara
    Cillo, Umberto
    Gasbarrini, Antonio
    Toniutto, Pierluigi
    Fagiuoli, Stefano
    Burra, Patrizia
    HEPATOLOGY, 2009, 50 (04) : 549A - 549A
  • [30] Sofosbuvir and ribavirinin in hcv-infected patients listed for liver transplantation: a cost-effectiveness analysis
    Cortesi, Paolo A.
    Mantovani, Lorenzo G.
    Ciaccio, Antonio
    Rota, Matteo
    Cesana, Giancarlo
    Strazzabosco, Mario
    Belli, Luca S.
    HEPATOLOGY, 2014, 60 : 534A - 534A
12345